Bipharma company information, Employees & Contact Information

SCHOTT Pharma Launches Next Gen Polymer Syringe System Contract Pharma

2024 drug approvals: Small companies loom large with several key FDA nods Fierce Pharma

Pint Pharma Announces ANVISA’s Approval of BESREMi® (ropeginterferon alfa-2b) for the Treatment of Polycythemia Vera Business Wire

Rentschler Biopharma announces strategic realignment of its global business operations GlobeNewswire

Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech The Manila Times

OnCusp’s CUSP06 Receives FDA Fast Track Designation Contract Pharma

JPM25: After taking the wheel at Acadia, CEO Catherine Owen Adams looks to steer firm toward $1B in sales Fierce Pharma

EyePoint Investor Relations EyePoint Pharmaceuticals

Global Biotechnology Company Global Biotechnology Company

Rentschler Biopharma announces largest single investment at its headquarters in Germany Yahoo Finance

Top 20 Pharma and BioPharma Companies Archives Contract Pharma

Mapi Pharma is Seeking New Depot Product Partnerships GlobeNewswire

Vetter Pharma International Contract Pharma

Two-thirds of top 20 pharmas have banned ChatGPT—and many in life sci call AI 'overrated,' survey finds Fierce Pharma

Pharmas are underutilizing social media to communicate with doctors and patients, HCPs say Fierce Pharma

Adragos Pharma Acquires Swiss Sterile Fill-Finish Firm Baccinex Contract Pharma

Sumitomo Pharma, suffering from sliding sales, lays off another 400 US staffers Fierce Pharma

Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on Fierce Pharma

As Vyvanse generics bite, Takeda sets out on $900M restructuring plan Fierce Pharma

The top 10 pharma drug ad spenders for 2022 Fierce Pharma

Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus Fierce Pharma

Recro Pharma rebrands itself as Societal CDMO in wake of Irisys purchase Fierce Pharma

Medicines From Purdue purduepharma.com

Pharmaceutical Aptar

CRO Industry Report Contract Pharma

After triumphant pilot, GSK eyes 'digital twins' to fine-tune vaccine production, development Fierce Pharma

Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts GlobeNewswire

LEO Pharma Closes Deal for Spevigo® Yahoo Finance

Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGO® (spesolimab) Yahoo Finance

Rentschler Biopharma further expands its services in Japan GlobeNewswire

Together We Build: Rentschler Biopharma celebrates construction progress of new buffer media facility, largest single investment at Laupheim site Yahoo! Finance UK

Coriolis Pharma Opens New Laboratory at Spark Life Science Campus in Morrisville, North Carolina Biotech Newswire

LEO Pharma presents two late-breaking abstracts for temtokibart reporting positive Phase 2b efficacy, safety and biomarker results in moderate-to-severe atopic dermatitis at the 2025 EADV Annual Meeting in Paris Yahoo Finance

Coriolis Pharma Appoints Peter Sölkner to Board of Directors to Support the Company’s Growth Ambitions Biotech Newswire

Brenus Pharma Publishes Promising Proof of Concept Results of their Therapeutic Platform in the Scientific Frontiers in Oncology Journal. (1) Business Wire

Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update Business Wire

SK Capital buys generics producer Apotex, troubled since the murder of founder Barry Sherman Fierce Pharma

Recordati to acquire EUSA Pharma for €750m, gaining 4 rare cancer drugs Fierce Pharma

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases Business Wire

Umoja Biopharma and TreeFrog Therapeutics announce collaboration to address current challenges facing ex vivo allogeneic therapies in immuno-oncology BioInformant

Pint Pharma Announces INVIMA’s Approval of ORLADEYO® (berotralstat), the First Oral Therapy for Preventing Hereditary Angioedema (HAE) Attacks in Patients Aged 12 and Older in Colombia Business Wire

Breeze Holdings Acquisition Corp. Shareholders Approve Business Combination with YD Biopharma Limited GlobeNewswire

Knight Therapeutics and Sumitomo Pharma enter into GlobeNewswire

NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer Business Wire

Yingli Pharma Doses First US Patient in Phase 1 Study of YL-13027 for Patients with Advanced Solid Tumors GlobeNewswire

Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR T and Engineered Induced Pluripotent Stem Cell Platform Technologies at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting Yahoo Finance

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project Business Wire

Umoja Biopharma Announces Appointment of Britton Russell as Chief Financial Officer GlobeNewswire

Rentschler Biopharma Inc Massachusetts Biotechnology Council

Umoja Biopharma Appoints Greg Sargen to its Board of Directors PR Newswire

Pint Pharma announces the approval of ORLADEYO® (berotralstat), the first oral therapy indicated to prevent hereditary angioedema (HAE) attacks in adults and children 12 years and older in Peru. Business Wire

Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer PR Newswire

Taiwan Biotech YD Biopharma Secures Path to Nasdaq Through Breeze Holdings SPAC Merger Approval Stock Titan

Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange Investing News Network

Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform PR Newswire

Biopharma Manufacturing Markets Contract Pharma

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH GlobeNewswire

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. Fierce Pharma

LEO Pharma appoints new Chief Financial Officer and Executive Vice President Via Ritzau

Biopharma Nomenclature Contract Pharma

LEO Pharma A/S appoints Brian Hilberdink new President of LEO Pharma Inc. United States Via Ritzau

Top 50 (or so) Biopharma Products Contract Pharma

Celtic Pharma targets $1.5bn for drug makers Financial News London

LEO Pharma strengthens global leadership team with appointment of new EVP People & Communications Via Ritzau